DAPAgliflozin Sodium Water glucosE EffecTs in Patients at High Cardiovascular Risk

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study aims to elucidate the impact of SGLT2 inhibition on peripheral vascular function, renal function, fluid volume, neurohormonal activation and inflammatory/fibrotic pathways in patients with T2D at high cardiovascular risk and non-T2D patients.
Epistemonikos ID: 71c40300cb220b2699fd1c7bacd1d19bb782e079
First added on: May 07, 2024